CorMedix Inc.CRMDNASDAQ
LOADING
|||
Net Income Growth Accelerating
Trending higher, above historical average, modest growth trend.
Left:
||||
Year-over-year net income growth rate
Latest
447.52%
↑ 38541% above average
Average (39q)
1.16%
Historical baseline
Range
High:584.89%
Low:-656.27%
CAGR
+8.7%
Consistent expansion
| Period | Value |
|---|---|
| Q3 2025 | 447.52% |
| Q2 2025 | -3.95% |
| Q1 2025 | 53.32% |
| Q4 2024 | 584.89% |
| Q3 2024 | 80.38% |
| Q2 2024 | 2.17% |
| Q1 2024 | 1.95% |
| Q4 2023 | -51.41% |
| Q3 2023 | 13.56% |
| Q2 2023 | -6.68% |
| Q1 2023 | -28.73% |
| Q4 2022 | -19.77% |
| Q3 2022 | 9.88% |
| Q2 2022 | -8.08% |
| Q1 2022 | 9.69% |
| Q4 2021 | 9.08% |
| Q3 2021 | -84.97% |
| Q2 2021 | 35.80% |
| Q1 2021 | -18.56% |
| Q4 2020 | 7.78% |
| Q3 2020 | -74.51% |
| Q2 2020 | 31.94% |
| Q1 2020 | -4.76% |
| Q4 2019 | -0.76% |
| Q3 2019 | -656.27% |
| Q2 2019 | 86.53% |
| Q1 2019 | -340.53% |
| Q4 2018 | 120.99% |
| Q3 2018 | -19.62% |
| Q2 2018 | 15.99% |
| Q1 2018 | 1.22% |
| Q4 2017 | -3.56% |
| Q3 2017 | -93.47% |
| Q2 2017 | 32.26% |
| Q1 2017 | -18.71% |
| Q4 2016 | 29.88% |
| Q3 2016 | -86.75% |
| Q2 2016 | -15.50% |
| Q1 2016 | -9.44% |
| Q4 2015 | 17.54% |